Daily MedNews from drugs.com
MONDAY, Aug. 2, 2021 -- The pandemic widely disrupted medical care across the United States, but a new study reports that clinical trials testing […]
MONDAY, Aug. 2, 2021 -- Kids who are around people who use marijuana may be at risk for more colds and respiratory infections due to secondhand […]
MONDAY, Aug. 2, 2021 -- U.S. health officials have some reassuring news about the safety of the COVID-19 vaccine in young people: Among millions of […]
MONDAY, Aug. 2, 2021 (American Heart Association News) -- A first heart attack is a serious, life-changing event, although most people now survive […]
MONDAY, Aug. 2, 2021 -- All pregnant women should be vaccinated "without delay" against COVID-19, two leading groups of U.S. obstetric specialists […]
Latest headlines from Pharmacy Times
Pharmacy Times interviewed Craig Freyer, PharmD, BCOP, and Andrew Lin, PharmD, BCOP, to discuss how to manage the logistical challenges that arise during the administration of CAR T therapy in inpatient and outpatient settings for patients with multiple myeloma.
The analysis used AstraZeneca’s global safety database, which contains all spontaneously reported adverse events from real-world use of its medicines and vaccines worldwide.
Anifrolumab is a first-in-class type I interferon receptor antibody and is the only new treatment in more than a decade for this patient population.
Camber Pharmaceuticals is pleased to announce that it has added the 5 mg strength to their current product portfolio for Baclofen Tablets, which is the generic version of Lioresal.
The gluten-like proteins found in ryegrass could be interacting with crops commonly used as wheat replacements, which may cause a reaction among people with celiac or gluten intolerance.
Press Releases from the U.S. Food and Drug Administration
Coronavirus (COVID-19) Update: July 30, 2021
FDA Approves First Interchangeable Biosimilar Insulin Product for Treatment of Diabetes; Availability Will Help Increase Access and Potentially Lower the Cost of Insulin for People with Diabetes
FDA issued a warning letter to Visible Vapors LLC advising that marketing its tobacco products without premarket authorization, is illegal, and they can’t be sold or distributed in the U.S.
Coronavirus (COVID-19) Update: July 23, 2021
Coronavirus (COVID-19) Update: July 20, 2021